Boaoxin
A global R&D biotechnology company committed to developing antibody-based therapies to improve patient outcomes for the treatment of immune and oncologic diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD188m (Public information from Apr 2023)
Nanjing Jiangsu (HQ)
Authorizing premium user...